Wealth Advisors of Tampa Bay’s GSK GSK Stock Holding History

Wealth Advisors of Tampa Bay’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-40,830	Closed	-$2.22M	–	97
2022 Q1	$2.22M	Sell	40,830 -207	-0.5%	-$11.2K	0.6%	54
2021 Q4	$2.26M	Buy	41,037 +20,531	+100%	+$1.07M	0.55%	61
2021 Q3	$979K	Sell	20,506 -606	-3%	-$30.4K	0.54%	61
2021 Q2	$1.05M	Sell	21,112 -8,018	-28%	-$385K	0.58%	58
2021 Q1	$1.3M	Buy	29,130 +7,542	+35%	+$342K	0.77%	56
2020 Q4	$993K	Sell	21,588 -423	-2%	-$19.4K	0.69%	53
2020 Q3	$1.04M	Buy	22,011 +198	+0.9%	+$9.92K	0.77%	49
2020 Q2	$1.11M	Buy	21,813 +160	+0.7%	+$8.21K	0.93%	46
2020 Q1	$1.03M	Buy	21,653 +1,443	+7%	+$77K	1.15%	36
2019 Q4	$1.19M	Sell	20,210 -290	-1%	-$16.1K	1.09%	35
2019 Q3	$1.09M	Sell	20,500 -656	-3%	-$33.7K	0.91%	44
2019 Q2	$1.06M	Buy	+21,156	New	+$1.06M	0.77%	46

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Wealth Advisors of Tampa Bay's GSK Position: Q2 2022 in Review

Wealth Advisors of Tampa Bay sold out of GSK (GSK) in Q2 2022, closing a stake of 40,830 shares — an estimated $2.22M sold.

Wealth Advisors of Tampa Bay first reported a position in GSK in Q2 2019 and held it in 12 quarters. The position peaked at $2.26M in Q4 2021. 901 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

Wealth Advisors of Tampa Bay reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
Wealth Advisors of Tampa Bay sold 40,830 GSK shares in Q2 2022, an estimated $2.22M.
Wealth Advisors of Tampa Bay first reported a position in GSK in Q2 2019 and held it in 12 quarters.
Wealth Advisors of Tampa Bay's GSK position peaked at $2.26M in Q4 2021.
901 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Wealth Advisors of Tampa Bay's 13F filing for Q2 2022, filed 18 Jul 2022.